Yokoi Hideto, Sakai Atsushi, Kodama Tomonori, Magome Shogo, Nagayasu Tadanori, Tawara Masayuki, Hasegawa Taizo, Yasaka Takahiro, Abe Takeru, Takeuchi Ichiro
Department of Emergency Medicine, Yokohama City University, 4-57 Urafunecho Minami-ku Yokohama, Kanagawa, 232-0024, Japan; Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan.
The Japan Snake Institute, 3318 Yabuzuka-cho, Ohata, Gunma, 379-2301, Japan.
Toxicon. 2020 Dec;188:142-149. doi: 10.1016/j.toxicon.2020.10.027. Epub 2020 Oct 29.
Gloydius tsushimaensis is an endemic species inhabiting only Tsushima, a remote Japanese island, and is a distinct species from Gloydius blomhoffii widely distributed throughout mainland Japan and Gloydius brevicaudus and Gloydius ussuriensis which are geographically distributed in South Korea. This is the first multicenter retrospective study of G. tsushimaensis bites in Japan. A study of seventy-two patients who visited the former Izuhara Hospital, the former Naka Tsushima Hospital, Tsushima Hospital, and Kamitsushima Hospital during the fourteen years from January 1, 2005, to December 31, 2018, revealed the typical clinical characteristics of G. tsushimaensis bites. Five out of seventy-two cases (6.9%) showed severe hypofibrinogenemia, in which fibrinogen levels were below 100 mg/dl, which is an unreported clinical finding for G. blomhoffii bites. Generally, when fibrinogen levels are lower than 100 mg/dl, the bleeding risk increases, and it is perilous. Severe hypofibrinogenemia cases did not improve after G. blomhoffii antivenom administration. Additionally, all five cases had disseminated intravascular coagulation, and there were two cases of acute kidney injury and one death. five cases had a median maximum creatine kinase level of 5171 IU/l (Interquartile range: 4992-41,310). Although the mechanism is not precise, coagulation tests showed that the G. tsushimaensis venom contains a thrombin-like enzyme. Based on this research, we created an algorithm for the treatment of G. tsushimaensis bites and unified the treatment methods used on the island.
日本蝮是一种仅栖息于日本偏远岛屿对马岛的特有物种,它与广泛分布于日本本土的日本蝮、地理分布于韩国的短尾蝮和乌苏里蝮是不同的物种。这是日本首次对日本蝮咬伤进行的多中心回顾性研究。一项对2005年1月1日至2018年12月31日这14年间前往原泉原医院、原中对马医院、对马医院和上对马医院就诊的72例患者的研究,揭示了日本蝮咬伤的典型临床特征。72例病例中有5例(6.9%)出现严重低纤维蛋白原血症,纤维蛋白原水平低于100mg/dl,这是日本蝮咬伤未报告的临床发现。一般来说,当纤维蛋白原水平低于100mg/dl时,出血风险增加,情况危险。给予日本蝮抗蛇毒血清后,严重低纤维蛋白原血症病例并未改善。此外,所有5例均发生弥散性血管内凝血,有2例急性肾损伤,1例死亡。5例患者的肌酸激酶最高水平中位数为5171IU/l(四分位间距:4992 - 41310)。尽管机制尚不清楚,但凝血试验表明日本蝮毒液含有一种类凝血酶样酶。基于这项研究,我们创建了日本蝮咬伤的治疗算法,并统一了岛上使用的治疗方法。